Down-regulation of anti-CD3 antibody-induced IL-4 production by bovine caseins hydrolysed with Lactobacillus GG-derived enzymes

被引:127
作者
Sutas, Y
Hurme, M
Isolauri, E
机构
[1] TAMPERE UNIV, SCH MED, SF-33101 TAMPERE 10, FINLAND
[2] TAMPERE UNIV HOSP, SCH MED, DEPT PEDIAT, TAMPERE, FINLAND
[3] TAMPERE UNIV HOSP, DEPT IMMUNOL & MICROBIOL, TAMPERE, FINLAND
关键词
D O I
10.1046/j.1365-3083.1996.d01-258.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A prerequisite for systemic hyporesponsiveness to dietary antigens is their processing in the gut. This study investigated whether bovine caseins degraded by enzymes of an intestinal bacterial strain, Lactobacillus GG (ATCC 53103), could regulate the cytokine production by anti-CD3 antibody-induced peripheral blood mononuclear cells of 14 atopic patients, aged 5-29 (mean, 16) months. Purified casein up-regulated the interleukin-4 and interferon-gamma production, P = 0.008 and P = 0.008, respectively. Conversely, Lactobacillus GG-degraded casein down-regulated the interleukin-4 production, P = 0.003, with no effect on interferon-gamma. These results indicate that intestinal bacteria may modify immunomodulatory properties of native food proteins and introduce a promising tool to provide protection from potentially harmful dietary antigens at a young age.
引用
收藏
页码:687 / 689
页数:3
相关论文
共 11 条
[1]  
HANIFIN JM, 1987, MONOGR ALLERGY, V21, P116
[2]  
Hattevig G, 1993, Pediatr Allergy Immunol, V4, P182, DOI 10.1111/j.1399-3038.1993.tb00089.x
[3]   THE NATURAL IMMUNE-RESPONSE TO INHALED SOLUBLE-PROTEIN ANTIGENS INVOLVES MAJOR HISTOCOMPATIBILITY COMPLEX (MHC) CLASS-I RESTRICTED CD8+ T-CELL MEDIATED BUT MHC CLASS-II RESTRICTED CD4+ T-CELL-DEPENDENT IMMUNE DEVIATION RESULTING IN SELECTIVE SUPPRESSION OF IMMUNOGLOBULIN-E PRODUCTION [J].
MCMENAMIN, C ;
HOLT, PG .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (03) :889-899
[4]   IGE PRODUCTION BY NORMAL HUMAN-LYMPHOCYTES IS INDUCED BY INTERLEUKIN-4 AND SUPPRESSED BY INTERFERON-GAMMA AND INTERFERON-ALPHA AND PROSTAGLANDIN-E2 [J].
PENE, J ;
ROUSSET, F ;
BRIERE, F ;
CHRETIEN, I ;
BONNEFOY, JY ;
SPITS, H ;
YOKOTA, T ;
ARAI, N ;
ARAI, KI ;
BANCHEREAU, J ;
DEVRIES, JE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1988, 85 (18) :6880-6884
[5]  
PENG HJ, 1990, CLIN EXP IMMUNOL, V81, P510
[6]   ALLERGEN IMMUNOTHERAPY DECREASES INTERLEUKIN-4 PRODUCTION IN CD4+ T-CELLS FROM ALLERGIC INDIVIDUALS [J].
SECRIST, H ;
CHELEN, CJ ;
WEN, Y ;
MARSHALL, JD ;
UMETSU, DT .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (06) :2123-2130
[7]  
STROBEL S, 1985, IMMUNOLOGY, V56, P57
[8]  
SUTAS Y, 1996, IN PRESS J ALLERGY C
[9]  
SYVAOJA EL, 1992, MILCHWISSENSCHAFT, V47, P563
[10]   INDUCTION OF HUMAN IGE SYNTHESIS REQUIRES INTERLEUKIN-4 AND T/B CELL-INTERACTIONS INVOLVING THE T-CELL RECEPTOR CD3 COMPLEX AND MHC CLASS-II ANTIGENS [J].
VERCELLI, D ;
JABARA, HH ;
ARAI, KI ;
GEHA, RS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1989, 169 (04) :1295-1307